Advertisement

Topics

Sales hopes for new Novartis, Merck heart drugs under microscope

03:24 EDT 29 Jun 2017 | Reuters

LONDON (Reuters) - Novartis and Merck have both surprised experts in the past week by finding new ways to tackle heart disease, although the jury remains out as to whether this scientific success will translate into blockbuster sales.

Original Article: Sales hopes for new Novartis, Merck heart drugs under microscope

NEXT ARTICLE

More From BioPortfolio on "Sales hopes for new Novartis, Merck heart drugs under microscope"

Quick Search
Advertisement
 

Relevant Topics

Biotechnology Business
Alliances Astrazeneca Bioethics Boehringer Clinical Research Organization Collaborations GSK Johnson & Johnson Lilly Merck Mergers and Acquisitions Nexium Novartis Pfizer Roche Sanofi ...

Merck and Co
Merck & Co is the 7th largest pharmaceutical company in the world based on annual sales, which reached $25,236m in 2009. They have developed 14 vaccines and over 40 prescription products in the major therapeutic areas of cardiovascular disease, respi...